TY - JOUR
T1 - Identification of Dietary Supplements Associated with Blood Metabolites in the Hispanic Community Health Study/Study of Latinos Cohort Study
AU - Kaplan, Robert C.
AU - Williams-Nguyen, Jessica S.
AU - Huang, Yuhan
AU - Mossavar-Rahmani, Yasmin
AU - Yu, Bing
AU - Boerwinkle, Eric
AU - Gellman, Marc D.
AU - Daviglus, Martha
AU - Chilcoat, Aisha
AU - Van Horn, Linda
AU - Faurot, Kim
AU - Qi, Qibin
AU - Greenlee, Heather
N1 - Funding Information:
The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (HHSN268201300001I/N01-HC-65233), University of Miami (HHSN268201300004I/N01-HC-65234), Albert Einstein College of Medicine (HHSN268201300002I/N01-HC-65235), University of Illinois at Chicago (HHSN268201300003I/N01-HC-65236 Northwestern Univ), and San Diego State University (HHSN268201300005I/N01-HC-65237). The following Institutes/Centers/Offices have contributed to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. Additional funding was provided through R01DK119268 and R01HL060712. Dr. Yu was in part supported by R01HL141824. The funders had no role in the design or interpretation of this study.
Funding Information:
The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina ( HHSN268201300001I/N01-HC-65233 ), University of Miami ( HHSN268201300004I/N01-HC-65234 ), Albert Einstein College of Medicine ( HHSN268201300002I/N01-HC-65235 ), University of Illinois at Chicago ( HHSN268201300003I/N01-HC-65236 Northwestern Univ ), and San Diego State University ( HHSN268201300005I/N01-HC-65237 ). The following Institutes/Centers/Offices have contributed to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. Additional funding was provided through R01DK119268 and R01HL060712. Dr. Yu was in part supported by R01HL141824. The funders had no role in the design or interpretation of this study.
Publisher Copyright:
© 2023
PY - 2023/5
Y1 - 2023/5
N2 - Background: Metabolomics approaches have been widely used to define the consumption of foods but have less often been used to study exposure to dietary supplements. Objectives: This study aimed to identify dietary supplements associated with metabolite levels and to examine whether these metabolites predicted incident diabetes risk. Methods: We studied 3972 participants from a prospective cohort study of 18–74-y-old Hispanic/Latino adults. At a baseline examination, we ascertained use of dietary supplements using recall methods and concurrently, a serum metabolomic panel. After adjustment for potential confounders, we identified dietary supplements associated with metabolites. We then examined the association of these metabolites with incident diabetes at the 6-y study examination. Results: We observed a total of 110 dietary supplement–metabolite associations that met the criteria for statistical significance adjusted for age, sex, field center, Hispanic/Latino background, body mass index, diet, smoking, physical activity, and number of medications (adjusted P < 0.05). This included 13 metabolites uniquely associated with only one dietary supplement ingredient. Vitamin C had the most associated metabolites (n = 15), including positive associations with oxalate, tartronate, threonate, and isocitrate, which were each in turn protective for the risk of incident diabetes. Vitamin C was also associated with higher N-acetylvaline level, which was an unfavorable diabetes risk factor. Other findings related to branched chain amino acid related compounds including α-hydroxyisovalerate and 2-hydroxy-3-methylvalerate, which were inversely associated with thiamine or riboflavin intake and also predicted higher diabetes risk. Vitamin B12 had an inverse association with γ-glutamylvaline, levels of which were positively associated with the risk of diabetes. Conclusions: Our data point to potential metabolite changes associated with vitamin C and B vitamins, which may have favorable metabolic effects. Knowledge of blood metabolites that can be modified by dietary supplement intake may aid understanding the health effects of dietary supplements and identify potential biological mediators.
AB - Background: Metabolomics approaches have been widely used to define the consumption of foods but have less often been used to study exposure to dietary supplements. Objectives: This study aimed to identify dietary supplements associated with metabolite levels and to examine whether these metabolites predicted incident diabetes risk. Methods: We studied 3972 participants from a prospective cohort study of 18–74-y-old Hispanic/Latino adults. At a baseline examination, we ascertained use of dietary supplements using recall methods and concurrently, a serum metabolomic panel. After adjustment for potential confounders, we identified dietary supplements associated with metabolites. We then examined the association of these metabolites with incident diabetes at the 6-y study examination. Results: We observed a total of 110 dietary supplement–metabolite associations that met the criteria for statistical significance adjusted for age, sex, field center, Hispanic/Latino background, body mass index, diet, smoking, physical activity, and number of medications (adjusted P < 0.05). This included 13 metabolites uniquely associated with only one dietary supplement ingredient. Vitamin C had the most associated metabolites (n = 15), including positive associations with oxalate, tartronate, threonate, and isocitrate, which were each in turn protective for the risk of incident diabetes. Vitamin C was also associated with higher N-acetylvaline level, which was an unfavorable diabetes risk factor. Other findings related to branched chain amino acid related compounds including α-hydroxyisovalerate and 2-hydroxy-3-methylvalerate, which were inversely associated with thiamine or riboflavin intake and also predicted higher diabetes risk. Vitamin B12 had an inverse association with γ-glutamylvaline, levels of which were positively associated with the risk of diabetes. Conclusions: Our data point to potential metabolite changes associated with vitamin C and B vitamins, which may have favorable metabolic effects. Knowledge of blood metabolites that can be modified by dietary supplement intake may aid understanding the health effects of dietary supplements and identify potential biological mediators.
KW - Hispanic
KW - Latino
KW - diabetes mellitus
KW - diet
KW - dietary supplements
KW - epidemiology
KW - metabolomics
KW - minerals
KW - risk factors
KW - vitamins
UR - http://www.scopus.com/inward/record.url?scp=85151020501&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151020501&partnerID=8YFLogxK
U2 - 10.1016/j.tjnut.2023.02.021
DO - 10.1016/j.tjnut.2023.02.021
M3 - Article
C2 - 36822396
AN - SCOPUS:85151020501
SN - 0022-3166
VL - 153
SP - 1483
EP - 1492
JO - Journal of Nutrition
JF - Journal of Nutrition
IS - 5
ER -